This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Drug Therapy, Other  • Infectious Diseases  • Infectious Diseases, Other  • Ophthalmological Disorders, Other  • Cardiovascular System  • Cardiovascular System, Other  • Drug Therapy  • Alert me on articles by topic

Christopher D. Gelston, MD; Vikram D. Durairaj, MD; Eric A. F. Simoes, MD

Arch Ophthalmol. 2007;125(6):848-849.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Rhino-orbital mucormycosis usually leads to acutely fatal fungal infections in immunocompromised patients through central nervous system invasion or vascular thrombosis. Historically, untreated orbital mucormycosis has a survival rate of 24%, but the recent combination of surgical debridement and amphotericin B has improved patient survival to 85%.^1-2 Ophthalmologists are often involved in making medical and surgical decisions in these complex cases; therefore, it is important to be aware of advances in the management of this disorder. We describe herein a case of rhino-orbital mucormycosis and cavernous sinus and internal carotid thrombosis treated with posaconazole after the failure of initial treatment with surgical debridement and amphotericin B.

Report of a Case

A 7-year-old girl with poorly controlled diabetes was seen at a nearby hospital for a 2-day history of left eyelid swelling and pain. After 2 days of treatment with intravenous ceftriaxone sodium . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of Radiopaque Intraorbital Catheter in the Treatment of Sino-Orbito-Cranial Mucormycosis
Kahana and Lucarelli
Arch Ophthalmol 2007;125:1714-1715.
FULL TEXT